Y-Biologics (XKRX:338840) Stock Based Compensation : ₩879 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Stock Based Compensation?

Y-Biologics's Stock Based Compensation for the three months ended in Mar. 2025 was ₩209 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was ₩879 Mil.

Y-Biologics Stock Based Compensation Historical Data

The historical data trend for Y-Biologics's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Stock Based Compensation Chart

Y-Biologics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Stock Based Compensation

Get a 7-Day Free Trial

1,169.33

1,570.15

2,606.72

2,096.89

1,188.68

Y-Biologics Quarterly Data
	Dec17	Dec18	Dec19	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Stock Based Compensation	Get a 7-Day Free Trial													517.93	375.27	283.43	12.05	208.73

Y-Biologics Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩879 Mil.

Y-Biologics Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

B715 Daedeok Biz Center, 17 Techno 4-ro, Yuseong-gu, Daejeon, KOR, 34013

Website

https://www.ybiologics.com

Y-Biologics Inc is a company that has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of the development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics Headlines

No Headlines